Search Results - "Grant, Marianne K.O."

Refine Results
  1. 1
  2. 2

    CYP1B1 as a therapeutic target in cardio-oncology by Carrera, Alexa N, Grant, Marianne K O, Zordoky, Beshay N

    Published in Clinical science (1979) (13-11-2020)
    “…Cardiovascular complications have been frequently reported in cancer patients and survivors, mainly because of various cardiotoxic cancer treatments. Despite…”
    Get more information
    Journal Article
  3. 3

    Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway by Dabour, Mohamed S., Abdelgawad, Ibrahim Y., Grant, Marianne K.O., El-Sawaf, Engie S., Zordoky, Beshay N.

    Published in Biomedicine & pharmacotherapy (01-08-2023)
    “…Carfilzomib (CFZ) is a proteasome inhibitor approved for relapsed/refractory multiple myeloma (MM) but its clinical use is limited by cardiovascular toxicity…”
    Get full text
    Journal Article
  4. 4

    Losmapimod ameliorates doxorubicin-induced cardiotoxicity through attenuating senescence and inflammatory pathways by Dabour, Mohamed S., Abdelgawad, Ibrahim Y., Sadaf, Bushra, Daniel, Mary R., Grant, Marianne K.O., Seelig, Davis, Zordoky, Beshay N.

    Published in Biomedicine & pharmacotherapy (01-10-2024)
    “…Irreversible cardiotoxicity limits the clinical application of doxorubicin (DOX). DOX-induced cardiotoxicity has been associated with induction of senescence…”
    Get full text
    Journal Article
  5. 5

    Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation by Grant, Marianne K O, Abdelgawad, Ibrahim Y, Lewis, Christine A, Zordoky, Beshay N

    “…Doxorubicin (DOX) is an effective chemotherapeutic agent used to treat a wide variety of malignancies. In addition to its multi-organ toxicity, DOX treatment…”
    Get full text
    Journal Article
  6. 6

    Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology by Abdelgawad, Ibrahim Y, Grant, Marianne K O, Zordoky, Beshay N

    Published in Nutrients (14-03-2019)
    “…Cardio-oncology is a clinical/scientific discipline which aims to prevent and/or treat cardiovascular diseases in cancer patients. Although a large number of…”
    Get full text
    Journal Article
  7. 7

    A Cautionary Tale: Endogenous Biotinylated Proteins and Exogenously-Introduced Protein A Cause Antibody-Independent Artefacts in Western Blot Studies of Brain-Derived Proteins by Grant, Marianne K O, Shapiro, Samantha L, Ashe, Karen H, Liu, Peng, Zahs, Kathleen R

    Published in Biological procedures online (18-04-2019)
    “…Antibodies are commonly used to detect or isolate proteins from biological samples. Much attention has been paid to the potential for poorly-characterized…”
    Get full text
    Journal Article
  8. 8

    Synthesis and evaluation of xanomeline analogs : Probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor by KANE, Brian E, GRANT, Marianne K. O, EL-FAKAHANY, Esam E, FERGUSON, David M

    Published in Bioorganic & medicinal chemistry (01-02-2008)
    “…A series of xanomeline analogs were synthesized and evaluated for binding at the M(1) muscarinic acetylcholine receptor (M(1) receptor). Specifically,…”
    Get full text
    Journal Article
  9. 9

    Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex by De Lorme, Kayla C, Grant, Marianne K O, Noetzel, Meredith J, Polson, Sonya B, El-Fakahany, Esam E

    “…Unlike other M1 muscarinic acetylcholine receptor agonists, xanomeline demonstrates a unique mode of binding to the receptor. It not only binds reversibly to…”
    Get more information
    Journal Article
  10. 10

    Therapeutic interventions targeting the nitric oxide system: Current and potential uses in obstetrics, bone disease and erectile dysfunction by Grant, Marianne K.O, El-Fakahany, Esam E

    Published in Life Sciences (20-02-2004)
    “…Nitric oxide is involved in a countless number of physiological processes and is known to have cytoprotective as well as cytotoxic effects. Increased knowledge…”
    Get full text
    Book Review Journal Article
  11. 11

    Endogenous expression of nNOS protein in several neuronal cell lines by Grant, Marianne K.O, Cuadra, Adolfo E, El-Fakahany, Esam E

    Published in Life sciences (1973) (05-07-2002)
    “…Several neuronal cell lines were screened for endogenous expression of neuronal nitric oxide synthase (nNOS) protein using Western blot analysis. Detectable…”
    Get full text
    Journal Article
  12. 12

    Doxorubicin Cardiotoxicity in Young Tumor‐Bearing Mice by Abdelgawad, Ibrahim Y., Grant, Marianne K.O., Lewis, Christine, Popescu, Flavia, Largaespada, David, Zordoky, Beshay N.

    Published in The FASEB journal (01-04-2020)
    “…Abstract only Background Childhood cancer survivors have about 15‐times higher risk of heart failure than their siblings mainly due to the cardiotoxicity of…”
    Get full text
    Journal Article
  13. 13

    Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice by Abdelgawad, Ibrahim Y., George, Benu, Grant, Marianne K. O., Huang, Yingbo, Shan, Yuting, Huang, R. Stephanie, Zordoky, Beshay N.

    Published in Archives of toxicology (01-04-2024)
    “…Cancer survivors may experience long-term cardiovascular complications due to chemotherapeutic drugs such as doxorubicin (DOX). The exact mechanism of delayed…”
    Get full text
    Journal Article
  14. 14

    Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction by Grant, Marianne K. O, Abdelgawad, Ibrahim Y, Lewis, Christine A, Seelig, Davis, Zordoky, Beshay N, Lionetti, Vincenzo

    Published in PloS one (09-07-2020)
    “…Sex-related differences in cardiovascular diseases are highly complex in humans and model-dependent in experimental laboratory animals. The objective of this…”
    Get full text
    Journal Article
  15. 15

    Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells by Abdelgawad, Ibrahim Y, Agostinucci, Kevin, Sadaf, Bushra, Grant, Marianne K O, Zordoky, Beshay N

    Published in Frontiers in aging (24-04-2023)
    “…Doxorubicin (DOX), a chemotherapeutic drug, induces senescence and increases the secretion of senescence-associated secretory phenotype (SASP) in endothelial…”
    Get full text
    Journal Article
  16. 16

    Doxorubicin Paradoxically Ameliorates Tumor-Induced Inflammation in Young Mice by Abdelgawad, Ibrahim Y, Grant, Marianne K O, Popescu, Flavia E, Largaespada, David A, Zordoky, Beshay N

    “…Doxorubicin (DOX) is one of the most widely used chemo-therapeutic agents in pediatric oncology. DOX elicits an inflammatory response in multiple organs, which…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments by Grant, Marianne K O, Handoko, Maureen, Rozga, Malgorzata, Brinkmalm, Gunnar, Portelius, Erik, Blennow, Kaj, Ashe, Karen H, Zahs, Kathleen R, Liu, Peng

    Published in PloS one (28-02-2019)
    “…In a previous study, we reported that levels of two types of protein species-a type of ~55-kDa species and a type of ~15-kDa species-are elevated in the lumbar…”
    Get full text
    Journal Article
  19. 19

    Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice by Agostinucci, Kevin, Grant, Marianne K O, Melaku, Wongel, Nair, Chandini, Zordoky, Beshay N

    Published in Pharmaceuticals (Basel, Switzerland) (01-03-2023)
    “…Sex is a salient risk factor in the development of doxorubicin-induced cardiotoxicity. Sex differences in the heart's ability to respond to hypertrophic…”
    Get full text
    Journal Article
  20. 20

    Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice by Grant, Marianne K O, Seelig, Davis M, Sharkey, Leslie C, Choi, Wan S V, Abdelgawad, Ibrahim Y, Zordoky, Beshay N

    Published in PloS one (20-02-2019)
    “…Doxorubicin (DOX) is a chemotherapeutic agent that has been reported to cause nephrotoxicity in rodent models and to a lesser degree in cancer patients. Female…”
    Get full text
    Journal Article